| Value | ₹2.90 Cr |
|---|
BSE filing, BSE: 542934. Summary written from the filing by ALFA Finder's alert engine.
Chandra Bhagat Pharma Ltd: key numbers
- Share price
- ₹47.18
- Market cap
- ₹35.60 Cr
- Revenue (annual)
- ₹116.3 Cr
- Net profit (annual)
- ₹3.05 Cr
- P/E (TTM)
- 11.7×Sector 46.1×
- Promoter holding
- 73.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chandra Bhagat Pharma Ltd
All →Chandra Bhagat Pharma Convertible Warrants
Chandra Bhagat Pharma allotted 50 lakh convertible warrants worth ₹21.90 Crore to seven promoter group members. Allotment was completed on 22 October 2026.
- Value
- ₹21.90 Cr
Chandra Bhagat Pharma Convertible Warrants
Chandra Bhagat Pharma allotted 66 lakh convertible warrants at Rs.44 each, raising Rs.7.26 Crore from 9 allottees. Warrants are convertible 1:1 into equity shares within 18 months.
- Value
- ₹7.26 Cr
Chandra Bhagat Pharma Other Announcement
Chandra Bhagat Pharma Ltd filed a certificate for non-applicability of corporate governance requirements for the September 2026 quarter. This exemption applies to SME-listed entities.
Chandra Bhagat Pharma Management Change
Ms. Rajani Dawani has resigned from her position as Company Secretary and Compliance Officer of Chandra Bhagat Pharma Limited, effective September 30, 2026.
Chandra Bhagat Pharma Annual General Meeting
Chandra Bhagat Pharma Limited conducted its 23rd Annual General Meeting on September 1, 2026, covering annual accounts, director reappointment, capital increase, and warrant issuance.
Chandra Bhagat Pharma Annual General Meeting
Chandra Bhagat Pharma Limited issued a corrigendum to its AGM notice regarding a proposed preferential issue. The update provides a web link to the required compliance certificate.
Other preferential issue announcements
All →One Global Service Provider Preferential Issue
One Global Service Provider allotted 7,06,068 preferential equity shares to two allottees, for consideration other than cash. Issue value is about Rs.39.54 Crore at the stated prices.
- Value
- ₹39.54 Cr
CCME Global Preferential Issue
CCME Global's Preferential Issue Committee allotted about 15.08 crore equity shares worth Rs 150.84 crore, including shares for cash and for acquiring stakes in CCME UAE and Interlink. Both entities become associate and subsidiary respectively from October 28, 2026.
- Value
- ₹150.8 Cr
Sharp Investments Preferential Issue
Sharp Investment disclosed that its proposed preferential issue is solely to acquire 100% of RLCPL via share swap. The shares carry a nominal Rs.1 face value with no cash consideration.
Avalon Technologies Preferential Issue
Avalon Technologies intimated an EGM on 21 Nov 2026 seeking approval for AoA alterations and a preferential issue of 19,37,808 warrants to Zollner Elektronik AG. The warrants aggregate about ₹425 Crore at ₹2,193.20 each.
- Value
- ₹425.0 Cr
- Execution
- Warrants exercisable for 18 months from allotment
Kuber Udyog Preferential Issue
Kuber Udyog's board approved allotting equity shares and warrants on preferential basis, valued at 276.13 Crore. A share swap acquires 100% of Golden Ikon Fleet Management.
- Value
- ₹276.1 Cr
ACI Infocom Preferential Issue
ACI Infocom allotted 3.2 crore shares and 10 crore warrants to Sanjay & Rupal Mandavia at ₹1.53 each, a ~₹20.20 Crore preferential issue.
- Value
- ₹20.20 Cr